Overview

Clinical and Structural Outcome of Conventional Versus Accelerated Corneal Collagen Cross-linking (CXL).

Status:
Unknown status
Trial end date:
2016-08-01
Target enrollment:
Participant gender:
Summary
Compare different corneal parameters and visual outcome of corneal collagen cross-linking (CXL) with conventional versus accelerated ultraviolet-A irradiation using riboflavin with hydroxypropyl methylcellulose.
Phase:
Phase 1/Phase 2
Details
Lead Sponsor:
Oslo University Hospital
Treatments:
Riboflavin